Concepedia

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma

Jeffrey R. Sawyer, E Tian, John D. Shaughnessy, Joshua Epstein, Charles M. Swanson, Colin Stangeby, C L Hale, Lewis G. Parr, Mike Lynn, Gael Sammartino,

Leukemia · 2016 · 32 citations · 34 references

Concepts

Life SciencesGeneticsHematologyCancer GeneticsCytogeneticsHematologic OncologyAneuploidyCancer CytogeneticsClinical CytogeneticsHematopoietic NeoplasmsMolecular CytogeneticsMultiple MyelomaCytogenetic AbnormalitiesCytogenetic Risk StratificationHigh-risk Multiple MyelomaMyeloma PathogenesisNeoplastic Cytogenetics

References

34

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

Public Health, Biostatistics, Mathematics +10

<b>mice</b>: Multivariate Imputation by Chained Equations in<i>R</i>

Stef van Buuren, Karin Groothuis‐Oudshoorn · Journal of Statistical Software · 2011 · 13.6K citations · Full text

Public Health, Biostatistics, Computational Biology +13

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

John D. Shaughnessy, Fenghuang Zhan, Bart Burington et al. · Blood · 2006 · 916 citations

Life Sciences, Genetics, Molecular Biology +12

Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

Shaji Kumar, Joseph Mıkhael, Francis K. Buadi et al. · Mayo Clinic Proceedings · 2009 · 625 citations · Full text

Medicine, Hematology, Oncology +14

Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013

Joseph Mıkhael, David Dingli, Vivek Roy et al. · Mayo Clinic Proceedings · 2013 · 495 citations

Medicine, Hematology, Oncology +15